Effects of Scutellarein on diabetic rat aorta

Acta Pharmacologica Sinica

Volumn 21, Issue 4, 2000, Pages 353-356

  Zhu, Bang Hao ^a   Guan, Yong Yuan ^a   He, Hua ^a   Lin, Mo Jun ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Acetylcholine; Experimental diabetes mellitus; Phenylepherine; Scutellarein; Streptozocin; Thoracic aorta; Vascular endothelium; Vasoconstriction; Vasodi lation

Indexed keywords

ACETYLCHOLINE; PHENYLEPHRINE; SCUTELLAREIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; ENDOTHELIUM INJURY; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; THORACIC AORTA; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ANIMALS; AORTA, THORACIC; ASTERACEAE; DIABETES MELLITUS, EXPERIMENTAL; DRUGS, CHINESE HERBAL; ENDOTHELIUM, VASCULAR; FLAVANONES; FLAVONOIDS; MALE; RATS; VASOCONSTRICTION; VASODILATION;

EID: 0034010836     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Pieper GM, Langenstroer P, Siebeneich W. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 1997; 34: 145-56.
2. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993; 88: 2510-6.
3. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 771-6.
4. Kawasaki H. Pharmacological studies on alterations in contractile reactivity in aortas isolated from experimental diabetic rats. Hokkaido Igaku Zasshi 1997; 72: 649-65.
5. Pelligrino DA, Koenig HM, Wang Q, Albrecht RF. Protein kinase C suppresses receptor-mediated pial arteriolar relaxation in the diabetic rat. Neuro Report 1994; 5: 417-20.
6. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 1991; 87: 432-8.
7. Pieper GM, Moore-Hilton G, Roza AM. Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sci 1996; 58: PL147-52.
8. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859-66.
9. Sakai Y, Inazu M, Shamoto A, Zhu B, Hommal. Contractile hyperreactivity and alteration of PKC activity in gastric fundus smooth muscle of diabetic rats. Pharmacol Biochem Behav 1994; 49: 669-74.
10. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 1996; 272: 728-31.
11. Xu G, Zhang LP, Shen HF, Hu CQ. Inhibition of protein kinase C by Scutellarein and its analogues. Acta Acad Med Shanghai 1993; 20: 187-91.
12. Shuai J, Dong WW. Experimental research of PKC inhibitor, Erigeron breviscapus on the ischemic/reperfusional brain injury. Chin Pharmacol Bull 1998; 14: 75-7.
13. Ozturk Y, Altan VM, Yildizoglu-Ari N. Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol Rev 1996; 48: 69-112.
14. Cameron NE, Cotter MA. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway activity. Diabetologia 1992; 35: 1011-9.